Ondine Biomedical Inc. (AIM:OBI)

Ondine Biomedical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5.32	10.57	9.77	2.98	13.13	30.37
Cash & Short-Term Investments	5.32	10.57	9.77	2.98	13.13	30.37
Cash Growth	-4.40%	8.18%	227.64%	-77.29%	-56.78%	4750.64%
Accounts Receivable	0.28	0.41	0.46	0.32	0.13	0.16
Other Receivables	0.02	0.05	0.06	0	0.05	0.09
Receivables	0.3	0.46	0.51	0.33	0.18	0.25
Inventory	2.04	1.82	1.27	1.07	1.29	1.06
Prepaid Expenses	0.17	0.41	0.48	0.22	0.38	1.83
Restricted Cash	-	-	0.16	0.16	0.15	-
Other Current Assets	-	0.01	-	-	-	-
Total Current Assets	7.83	13.26	12.19	4.75	15.13	33.5
Property, Plant & Equipment	1	1.07	0.6	0.95	1.4	0.6
Other Long-Term Assets	0.06	0.05	0.04	0.04	0.04	0.04
Total Assets	8.89	14.38	12.82	5.73	16.57	34.14

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.4	1.04	1.59	1.36	0.39	1.2
Accrued Expenses	10.27	9.31	4.19	1.75	3.16	2.08
Current Portion of Leases	0.28	0.31	0.17	0.38	0.36	0.15
Other Current Liabilities	0.14	0.14	-	-	-	0.5
Total Current Liabilities	12.09	10.8	5.95	3.49	3.91	3.92
Long-Term Debt	-	-	-	-	0.48	0.47
Long-Term Leases	-	0.1	-	0.16	0.54	0.09
Total Liabilities	12.09	10.9	5.95	3.65	4.93	4.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	296.93	288.19	262.6	239.65	235.04	235.04
Additional Paid-In Capital	10.53	10.53	10.53	10.53	10.53	10.53
Retained Earnings	-331.11	-314.95	-285.43	-266.33	-251.92	-232.54
Comprehensive Income & Other	20.45	19.71	19.18	18.24	18	16.64
Total Common Equity	-3.2	3.49	6.88	2.09	11.64	29.66
Shareholders' Equity	-3.2	3.49	6.88	2.09	11.64	29.66
Total Liabilities & Equity	8.89	14.38	12.82	5.73	16.57	34.14

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.28	0.41	0.17	0.54	1.38	0.71
Net Cash (Debt)	5.05	10.15	9.6	2.44	11.75	29.66
Net Cash Growth	0.66%	5.77%	293.40%	-79.23%	-60.39%	-
Net Cash Per Share	0.01	0.02	0.03	0.01	0.06	0.37
Filing Date Shares Outstanding	561.22	518.37	404	226.75	194.59	194.58
Total Common Shares Outstanding	561.22	518.37	404	226.75	194.59	194.58
Working Capital	-4.26	2.47	6.24	1.26	11.22	29.58
Book Value Per Share	-0.01	0.01	0.02	0.01	0.06	0.15
Tangible Book Value	-3.2	3.49	6.88	2.09	11.64	29.66
Tangible Book Value Per Share	-0.01	0.01	0.02	0.01	0.06	0.15
Machinery	1.74	1.62	1.21	0.99	1.95	1.77
Leasehold Improvements	0.42	0.3	0.33	0.31	0.29	0.28

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 15, 2026

Data Sources Report a data error